Because the vast majority of crashes are caused by humans, by human error, it may also save lives.
Anna Eshoo
The Public Record
Anna A. Eshoo is an American politician serving as the U.S. Representative for California's 16th congressional district since 2013. A member of the Democratic Party, she has been an advocate for various issues including healthcare, technology, and environmental protection. Eshoo has played a significant role in shaping policies related to telecommunications and has been involved in efforts to improve access to healthcare for her constituents.
This is going to require legislation, and I look forward to working with my colleagues to develop that legislation.
The FDA's world-class drug approval process ensures medicines do exponentially more good than harm to the American public.
HHS and the Biden administration have administered over 200 million COVID-19 vaccine doses.
The Biden administration has moved quickly to reverse the damage done to our healthcare system by the previous administration.
President Biden's fiscal year 2022 budget request continues these achievements by helping American families rebuild from the COVID-19 crisis healthier and safer than before.
I want to bring to your attention, sir, Woodrow Miller. He is a constituent of mine who is only 21 months old and, tragically, has Niemann-Pick Type C disease.
I do applaud the administration for this historic investment, as we know the block grant acts as an important safety net for some of our Nation's most vulnerable.
I have spoken to Woodrow's mother, Denise, and I want to do everything I can to help.
The problem that we have in the country is the following: Yes, we have the private sector, terrific, they all have a business plan.
I think the digital divide is a national embarrassment, and we have to solve it.
If you want to call affordability 'rate regulation,' well, tell your constituents that.
Today our subcommittee can help them by moving H.R. 3 forward, the Elijah E. Cummings Lower Drug Costs Now Act.
Negotiating for the prices of these drugs won't harm innovation in the future.
We can change that, and if we do, we will not only save lives, we will prevent bankruptcies across the country.
I think it is time to live up to our promises to lower the cost of prescription drugs for all our constituents.





